Date Action Amount Person Type
Mar 06, 2024 Buy 15 700 Vance Terry Stock Option (right to buy)
Mar 06, 2024 Buy 15 700 Russell Lesley Stock Option (right to buy)
Mar 06, 2024 Buy 15 700 Peterson Kristine Stock Option (right to buy)
Mar 06, 2024 Buy 15 700 Hata Yujiro S Stock Option (right to buy)
Mar 06, 2024 Buy 15 700 Foletta Mark G Stock Option (right to buy)
Mar 06, 2024 Buy 15 700 Carter Bruce L A Stock Option (right to buy)
Feb 26, 2024 Sell 5 187 Gardiner Nathaniel S. Stock Option (Right to Buy)
Feb 26, 2024 Buy 5 187 Gardiner Nathaniel S. Common Stock
Feb 12, 2024 Buy 3 320 Luu Brendan Common Stock
Feb 12, 2024 Sell 973 Luu Brendan Common Stock
Feb 12, 2024 Buy 3 320 Kieffer Tara Lynn Common Stock
Feb 12, 2024 Sell 973 Kieffer Tara Lynn Common Stock
Feb 12, 2024 Buy 3 320 Gardiner Nathaniel S. Common Stock
Feb 12, 2024 Sell 973 Gardiner Nathaniel S. Common Stock
Feb 12, 2024 Buy 2 576 Rottinghaus Scott T. Common Stock
Feb 12, 2024 Sell 755 Rottinghaus Scott T. Common Stock
Feb 12, 2024 Buy 3 680 Or Yat Sun Common Stock
Feb 12, 2024 Sell 1 080 Or Yat Sun Common Stock
Feb 12, 2024 Buy 3 320 Mellett Paul J Common Stock
Feb 12, 2024 Sell 973 Mellett Paul J Common Stock
Feb 12, 2024 Buy 5 400 Luly Jay R. Common Stock
Feb 12, 2024 Sell 1 584 Luly Jay R. Common Stock
Dec 13, 2023 Sell 15 295 Vance Terry Common Stock
Dec 05, 2023 Sell 2 125 Luu Brendan Common Stock
Dec 05, 2023 Sell 2 125 Kieffer Tara Lynn Common Stock
Dec 05, 2023 Sell 2 412 Gardiner Nathaniel S. Common Stock
Dec 05, 2023 Sell 534 Rottinghaus Scott T. Common Stock
Dec 05, 2023 Sell 2 412 Or Yat Sun Common Stock
Dec 05, 2023 Sell 2 412 Mellett Paul J Common Stock
Dec 05, 2023 Sell 7 230 Luly Jay R. Common Stock
Dec 01, 2023 Sell 753 Luu Brendan Common Stock
Dec 01, 2023 Sell 753 Kieffer Tara Lynn Common Stock
Dec 01, 2023 Sell 1 595 Gardiner Nathaniel S. Common Stock
Dec 01, 2023 Sell 1 595 Or Yat Sun Common Stock
Dec 01, 2023 Sell 1 595 Mellett Paul J Common Stock
Dec 01, 2023 Sell 5 787 Luly Jay R. Common Stock
Nov 22, 2023 Buy 83 000 Luu Brendan Stock Option (right to buy)
Nov 22, 2023 Buy 83 000 Kieffer Tara Lynn Stock Option (right to buy)
Nov 22, 2023 Buy 83 000 Mellett Paul J Stock Option (right to buy)
Nov 22, 2023 Buy 83 000 Gardiner Nathaniel S. Stock Option (right to buy)
Nov 22, 2023 Buy 86 000 Or Yat Sun Stock Option (right to buy)
Nov 22, 2023 Buy 86 000 Rottinghaus Scott T. Stock Option (right to buy)
Nov 22, 2023 Buy 264 000 Luly Jay R. Stock Option (right to buy)
Apr 18, 2023 Buy 6 667 Gardiner Nathaniel S. Common Stock
Apr 18, 2023 Sell 6 667 Gardiner Nathaniel S. Stock Option (Right to Buy)
Mar 16, 2023 Buy 5 800 Vance Terry Common Stock
Mar 16, 2023 Sell 5 800 Vance Terry Stock Option (right to buy)
Mar 15, 2023 Buy 10 440 Mellett Paul J Common Stock
Mar 15, 2023 Sell 100 Mellett Paul J Common Stock
Mar 15, 2023 Sell 10 340 Mellett Paul J Common Stock
Mar 15, 2023 Sell 10 440 Mellett Paul J Stock Option (Right to Buy)
Mar 15, 2023 Buy 13 925 Or Yat Sun Common Stock
Mar 15, 2023 Sell 269 Or Yat Sun Common Stock
Mar 15, 2023 Sell 13 656 Or Yat Sun Common Stock
Mar 15, 2023 Sell 13 925 Or Yat Sun Stock Option (Right to Buy)
Mar 13, 2023 Buy 27 912 Luly Jay R. Common Stock
Mar 13, 2023 Sell 10 697 Luly Jay R. Common Stock
Mar 13, 2023 Sell 15 649 Luly Jay R. Common Stock
Mar 13, 2023 Sell 1 566 Luly Jay R. Common Stock
Mar 13, 2023 Sell 27 912 Luly Jay R. Stock Option (Right to Buy)
Mar 02, 2023 Buy 10 800 Vance Terry Stock Option (right to buy)
Mar 02, 2023 Buy 10 800 Russell Lesley Stock Option (right to buy)
Mar 02, 2023 Buy 10 800 Peterson Kristine Stock Option (right to buy)
Mar 02, 2023 Buy 10 800 Hata Yujiro S Stock Option (right to buy)
Mar 02, 2023 Buy 10 800 Foletta Mark G Stock Option (right to buy)
Mar 02, 2023 Buy 10 800 Carter Bruce L A Stock Option (right to buy)
Feb 13, 2023 Buy 11 360 Luu Brendan Common Stock
Feb 13, 2023 Sell 6 416 Luu Brendan Common Stock
Feb 13, 2023 Buy 8 945 Luu Brendan Common Stock
Feb 13, 2023 Buy 11 747 Kieffer Tara Lynn Common Stock
Feb 13, 2023 Sell 6 725 Kieffer Tara Lynn Common Stock
Feb 13, 2023 Buy 9 250 Kieffer Tara Lynn Common Stock
Feb 13, 2023 Buy 11 747 Gardiner Nathaniel S. Common Stock
Feb 13, 2023 Sell 6 735 Gardiner Nathaniel S. Common Stock
Feb 13, 2023 Buy 9 250 Gardiner Nathaniel S. Common Stock
Feb 13, 2023 Buy 13 017 Or Yat Sun Common Stock
Feb 13, 2023 Sell 7 752 Or Yat Sun Common Stock
Feb 13, 2023 Buy 10 250 Or Yat Sun Common Stock
Feb 13, 2023 Buy 11 747 Mellett Paul J Common Stock
Feb 13, 2023 Sell 6 904 Mellett Paul J Common Stock
Feb 13, 2023 Buy 9 250 Mellett Paul J Common Stock
Feb 13, 2023 Buy 29 146 Luly Jay R. Common Stock
Feb 13, 2023 Sell 20 591 Luly Jay R. Common Stock
Feb 13, 2023 Buy 22 950 Luly Jay R. Common Stock
Feb 13, 2023 Buy 16 220 Luly Jay R. Common Stock
Feb 13, 2023 Buy 15 285 Luly Jay R. Common Stock
Feb 13, 2023 Sell 20 591 Luly Jay R. Common Stock
Feb 09, 2023 Sell 4 200 Mellett Paul J Common Stock
Feb 09, 2023 Sell 800 Mellett Paul J Common Stock
Jan 09, 2023 Buy 2 812 Mellett Paul J Common Stock
Jan 09, 2023 Sell 2 812 Mellett Paul J Stock Option (Right to Buy)
Dec 19, 2022 Buy 4 148 Mellett Paul J Common Stock
Dec 19, 2022 Sell 4 148 Mellett Paul J Stock Option (Right to Buy)
Dec 19, 2022 Buy 14 500 Luly Jay R. Common Stock
Dec 19, 2022 Sell 14 500 Luly Jay R. Stock Option (Right to Buy)
Dec 16, 2022 Buy 13 851 Luly Jay R. Common Stock
Dec 16, 2022 Sell 7 800 Luly Jay R. Common Stock
Dec 16, 2022 Buy 16 149 Luly Jay R. Common Stock
Dec 16, 2022 Sell 8 597 Luly Jay R. Common Stock
Dec 16, 2022 Sell 13 603 Luly Jay R. Common Stock
INSIDER POWER
67.553
Last 100 transactions
Buy: 1 263 491 | Sell: 308 316 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 67.553.

In total, the insiders bought 1 263 491 and sold 308 316 ENTA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT